The official Drugs@FDA dataset lists original submission 1 for NDA 021572 with status AP dated 2003-09-12, and names daptomycin among the application record's active ingredients.
The Federal Register published notice 03-20949, attributed to FDA and its parent HHS department, on 2003-08-18. Its official title is “Eli Lilly and Co. et al.; Withdrawal of Approval of 80 New Drug Applications and 75 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Histrelin and Secretin.
The Federal Register published rule 03-15618, attributed to FDA and its parent HHS department, on 2003-06-20. Its official title is “Dosage Form New Animal Drugs; Change of Sponsor; Technical Amendment,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.
The official Drugs@FDA dataset lists original submission 1 for NDA 021481 with status AP dated 2003-03-13, and names enfuvirtide among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for NDA 021488 with status AP dated 2003-02-13, and names leuprolide acetate among the application record's active ingredients.